Department of Obstetrics, Affiliated Hospital of Jining Medical University, Jining, P.R., China.
Eur Rev Med Pharmacol Sci. 2020 Feb;24(4):1672-1681. doi: 10.26355/eurrev_202002_20341.
To explore the regulatory mechanism of lncRNA NORAD on proliferation and invasion of ovarian cancer cells through miR-199a-3p.
Eighty-six ovarian cancer tissues and 86 tissues adjacent to cancer, human ovarian cancer cell lines SKOV3, HO-8910, A2780, OVCAR-3, and human normal ovarian epithelial cell line IOSE80 were collected. MiR-199a-3p-mimics, miR-199a-3p-inhibitor, miR-NC, si-NORAD, Sh-NORAD, and NC were transfected into HO-8910 and A2780 cells, the expression levels of lncRNA NORAD and miR-199a-3p in ovarian cancer tissues and cells were detected by qRT-PCR, and the expression levels of N-cadherin, E-cadherin, and vimentin in cells were detected by WB. Cell Counting Kit-8 (CCK-8), transwell, and cell scratch tests were used to detect proliferation, invasion, and migration of cells, and the relationship between lncRNA NORAD and miR-199a-3p was confirmed by the Dual-Luciferase reporter assay.
LncRNA NORAD was highly expressed and miR-199a-3p was lowly expressed in ovarian cancer, and the expression levels of LNCRNARAD and miR-199a-3p were negatively correlated. Cell experiments showed that inhibiting the expression of lncRNA NORAD or up-regulating the expression of miR-199a-3p could inhibit the proliferation, invasion, migration, and EMT of ovarian cancer cells, while up-regulating the expression of lncRNA NORAD or inhibiting the expression of miR-199a-3p could promote their proliferation, invasion, migration, and EMT. Dual-Luciferase reporter assay confirmed that there was a regulatory relationship between lncRNA NORAD and miR-199a-3p.
LncRNA NORAD was highly expressed in ovarian cancer tissues, while silencing lncRNA NORAD expression could inhibit the proliferation, invasion, migration, and EMT of ovarian cancer cells by regulating miR-199a-3p, which might be a new target for the diagnosis and treatment of ovarian cancer.
通过 miR-199a-3p 探讨长链非编码 RNA(lncRNA)NORAD 对卵巢癌细胞增殖和侵袭的调控机制。
收集 86 例卵巢癌组织和 86 例癌旁组织、人卵巢癌细胞系 SKOV3、HO-8910、A2780、OVCAR-3 和人正常卵巢上皮细胞系 IOSE80,转染 miR-199a-3p-模拟物、miR-199a-3p-抑制剂、miR-NC、si-NORAD、Sh-NORAD 和 NC 至 HO-8910 和 A2780 细胞,qRT-PCR 检测卵巢癌组织和细胞中 lncRNA NORAD 和 miR-199a-3p 的表达水平,WB 检测细胞中 N-钙黏蛋白、E-钙黏蛋白和波形蛋白的表达水平。细胞计数试剂盒-8(CCK-8)、Transwell 和细胞划痕试验分别用于检测细胞增殖、侵袭和迁移,双荧光素酶报告实验验证 lncRNA NORAD 和 miR-199a-3p 之间的关系。
lncRNA NORAD 在卵巢癌中高表达,miR-199a-3p 低表达,且两者的表达呈负相关。细胞实验表明,抑制 lncRNA NORAD 的表达或上调 miR-199a-3p 的表达可抑制卵巢癌细胞的增殖、侵袭和迁移及上皮间质转化(EMT),而上调 lncRNA NORAD 的表达或下调 miR-199a-3p 的表达则可促进其增殖、侵袭、迁移及 EMT。双荧光素酶报告实验证实 lncRNA NORAD 与 miR-199a-3p 之间存在调控关系。
lncRNA NORAD 在卵巢癌组织中高表达,沉默 lncRNA NORAD 表达可通过调节 miR-199a-3p 抑制卵巢癌细胞的增殖、侵袭、迁移和 EMT,可能成为卵巢癌诊断和治疗的新靶点。